Search Images Blogger Photos
Settings | Sign in

Pharmaceutical drug

See realtime coverage

Bill Ackman defends Valeant Pharmaceutical's drug development program on investor call

Financial Post - ‎Jul 20, 2016‎
Billionaire investor Bill Ackman defended Valeant Pharmaceuticals International Inc.'s research and development program, citing two drugs making their way toward the market and another just cleared. “People have mischaracterized Valeant's R&D programs ...

Is The Golden Era Of Pharmaceutical Profits Over?

Forbes - ‎11 hours ago‎
At least that's the suggestion of a study in Health Affairs by Ernst Berndt and colleagues, who analyzed revenues for pharmaceutical products released since the early '90s and found that the average lifetime sales of pharmaceutical drugs that make it ...
See realtime coverage

Fosun to buy Indian drug maker Gland Pharma

China Economic Review - ‎Jul 28, 2016‎
The Wall Street Journal reports a unit of China's Fosun Group has agreed to buy a controlling stake, roughly 86%, in Indian pharmaceutical company Gland Pharma Ltd. from shareholders including KKR & Co. for up to $1.26 billion. The deal is China's ...

M Pharmaceutical seeks to resurrect blockbuster obesity drug Orlistat

Financial Post - ‎Jul 21, 2016‎
The company has reformulated an anti-obesity treatment that achieved over $900 million in sales before an undesirable side effect reduced the drug's popularity. M Pharmaceutical interim CEO Brian Keane says the drug is going through expedited clinical ...

Say what you will about Donald Trump. He's right about drug companies

STAT - ‎Jul 22, 2016‎
As a physician, I believe that Trump is absolutely right about allowing cheaper pharmaceutical drugs manufactured abroad to be sold in the United States.
See realtime coverage

Amid opioid epidemic, rules for drug companies are loosened

Los Angeles Times - ‎Jul 27, 2016‎
Critics say it takes pressure off companies to detect and report drugs flowing to the black market. The top DEA official for regulation of pharmaceutical firms left the agency last fall, in part, he said, because of a bitter dispute with members of ...
See realtime coverage

Sun Pharma to get $50 mn for developing skin disease drug for Spanish firm Almirall

Firstpost - ‎Jul 27, 2016‎
Chennai: Indian drug major Sun Pharmaceutical Industries Ltd said it entered into $50 million licensing agreement with Spanish firm Almirall for the development and commercialisation of tildrakizumab for psoriasis in Europe.

BRIEF-Ahn-Gook Pharmaceutical signs drug sales contract worth 17.89 bln won

Reuters - ‎Jul 26, 2016‎
July 27 Ahn-Gook Pharmaceutical Co., Ltd.: * Says it signs contract with a China-based co, First Dragon International Development Limited, to provide impotency drug in mainland China. * Contract worth of 17.89 billion yuan. Source text in Korean: me2 ...
See realtime coverage

Owen Smith backed big pharma over use of cheaper drugs by NHS in 2010

The Guardian - ‎Jul 20, 2016‎
The leadership candidate, who worked as a drug company lobbyist before being elected to parliament, spoke in a parliamentary debate about epilepsy in 2010, warning that the government should be careful about “generic substitution of drugs” in treating ...

Pharmaceutical opioid addiction: patients delay treatment due to stigma

The Sydney Morning Herald - ‎Jul 26, 2016‎
When most Australians think of drug addiction, Jessica Khachan, from Sydney, is not the type of person who springs to mind.
See realtime coverage

Deal to save State €750m on pharmaceutical drugs

Irish Times - ‎Jul 20, 2016‎
The Government has signed a four-year deal with the pharmaceuticals sector that promises to deliver savings of €750 million on the State's drugs bill. It is expected those savings will provide scope for the HSE to pay for new, innovative treatments not ...

Teva agrees to largest-ever drug divestiture in FTC pharma merger case

ModernHealthcare.com - ‎Jul 27, 2016‎
As part of the agreement, Teva will divest anesthetics, antibiotics, weight loss drugs, oral contraceptives and drugs meant to treat ADHD, allergies, arthritis, cancers, diabetes, high blood pressure, high cholesterol, mental illnesses, opioid ...

Drug Transparency”: Each Bill Needs Careful Evaluation

Pharmaceutical Executive (press release) (registration) (blog) - ‎Jul 26, 2016‎
About a month ago, I received a breathless email from a colleague who was following the Vermont Drug Transparency debate in Montpelier.

BRIEF-Double Bond Pharmaceutical: Orphan Drug Designation for Temodex

Reuters - ‎Jul 26, 2016‎
July 26 Double Bond Pharmaceutical AB : * Said on Monday it had been officially granted Orphan Drug Designation (Orphan Drug) status for drug candidate Temodex by European Medicines Agency (EMA). * Approval applies to treatment of glioma, which is ...

How Valeant Cashed In Twice on Higher Drug Prices

New York Times - ‎10 hours ago‎
The mania surrounding Valeant Pharmaceuticals International hit its peak a year ago. Strange as it may seem today after all that has happened, on Aug. 5, 2015 - two weeks after a dazzling second-quarter earnings report - the drug company's stock ...
See realtime coverage

Cipla, Aurobindo Pharma to acquire drugs from Teva

VCCircle - ‎13 hours ago‎
Cipla Ltd and Aurobindo Pharma Ltd have agreed to acquire some generic drugs from Teva Pharmaceutical Industries Ltd in the US, as the Indian generic drugmakers seek to strengthen their presence in the world's largest pharmaceutical market.

The NHS would be crippled without big pharma

Spectator.co.uk (blog) - ‎Jul 21, 2016‎
Does Corbyn really want pharmaceutical companies excluded from medical research? There is a role for the Medical Research Council (MRC), but if you were going to rely on it to develop all drugs and treatments available on the NHS, then there isn't ...
ABPI hits back at Corbyn criticism of pharma
See realtime coverage

John McDonnell backtracks on Jeremy Corbyn's drug research policy, claiming he was 'misinterpreted'

Mirror.co.uk - ‎Jul 24, 2016‎
"And that medical research shouldn't be farmed out to big pharmaceutical companies like Pfizer and others but should be funded through the Medical Research Council.

Facing Cancer Drug Shortage, US Relies on Banned Chinese Plant

IndustryWeek - ‎Jul 22, 2016‎
The agency issued an indefinite ban on the factory in September, a first for Hisun, one of China's leading exporters of pharmaceuticals products. Yet to avoid possible shortages of drugs, the FDA allowed the plant to continue exporting about 15 ...

Indian pharma majors fail drug test

Hindustan Times - ‎Jul 18, 2016‎
NEW DELHI: Medicines made by Indian pharmaceutical companies including Cipla, Pfizer, Dr Reddy's, Lupin and Sun Pharmaceuticals among others have failed quality tests conducted by the drug controller general of India (DCGI), the apex drug standards ...
 -